AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT THIS AGREEMENT is made as of the 31st day of July, 2019.Securities Purchase Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • New York
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR UNDER ANY STATE SECURITIES LAWS, AND THE SECURITIES REPRESENTED HEREBY MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY (1) RULE 144 THEREUNDER, IF AVAILABLE, OR (2) 144A THEREUNDER, IF AVAILABLE, AND, IN EACH CASE, IN COMPLIANCE WITH APPLICABLE U.S. STATE SECURITIES LAWS, OR (D) WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY, PURSUANT TO ANOTHER EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PROVIDED THAT, IN THE CASE OF (C)(1) AND (D) ABOVE, AN OPINION OF COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE REASON
INDEMNITY AGREEMENT This Agreement is made effective as of the __rd day of ___________ 20__;Indemnity Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arizona
This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into and effective as of April 15, 2020 (the “Effective Date”), by and between 4Front Ventures Corp., a British Columbia corporation (the “Company”), and Joshua N. Rosen, an individual residing in the State of Arizona (the “Executive”).
ContractConstruction Loan Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Colorado
Exhibit 4.4 CONSTRUCTION LOAN AGREEMENT by and among LINCHPIN INVESTORS, LLC, A Delaware limited liability company And ITS WHOLLY-OWNED SUBSIDIARIES THAT MAY HEREAFTER BECOME PARTIES HERETO, Each as a Borrower, And LI LENDING, LLC a Delaware limited liability company, as Lender,
4FRONT HOLDINGS LLC AND 4FRONT CORP. AND 1196260 B.C. LTD. AND CANNEX CAPITAL HOLDINGS INC. BUSINESS COMBINATION AGREEMENT DATED MARCH 1, 2019Business Combination Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
STOCK PURCHASE AGREEMENT BY AND AMONG 4FRONT HOLDINGS LLC, PAUL OVERGAAG, NATHANIEL AVERILL, AND HEALTHY PHARMS, INC. November 13, 2018Stock Purchase Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
This STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 13, 2018, by and among Healthy Pharms, Inc., a Massachusetts corporation (the “Company”), Paul Overgaag, an individual (“Overgaag”), Nathaniel Averill, an individual (“Averill” and, together with Overgaag, “ Sellers” and each a “Seller”), and 4Front Holdings LLC, a Delaware limited liability company (“Buyer”). Capitalized terms used and not otherwise defined in this Agreement have the meanings set forth in Section 1.1.
LOCK-UP AGREEMENTLock-Up Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
This LOCK- UP AGREEMENT (this “Agreement”) is dated as of the 22nd day of August, 2019, by and among 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (the “Company”) and the shareholders of the Company named in Schedule “A” hereto (each, a “Shareholder”, together, the “Shareholders”, and together with the Company, the “Parties”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Illinois
This Loan and Security Agreement (this “Loan Agreement”) is made and entered into at Chicago, Illinois, on June 30, 2016, by and between Linchpin Investors LLC, a Delaware limited liability company (“Lender”), and IGM, LLC an Illinois limited liability company (“IGM”), Harborside Illinois Grown Medicine, Inc., an Illinois corporation (“Harborside”), and IL Grown Medicine LLC, an Illinois limited liability company (“Grown Medicine”) [Harborside and Grown Medicine are sometimes collectively referred to as “Borrowers”].
CONTRIBUTION AGREEMENTContribution Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Delaware
THIS CONTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of November 13, 2018, by and between 4Front Holdings LLC, a Delaware limited liability company (“Parent”), and Mission Partners USA, LLC, a Delaware limited liability company (“Sub”). The parties hereto are sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties.”
